Hvivo PLC (LON:HVO) insider James Winschel purchased 2,221 shares of the firm’s stock in a transaction on Tuesday, October 11th. The stock was bought at an average cost of GBX 180 ($2.23) per share, with a total value of £3,997.80 ($4,947.77).
Hvivo PLC (LON:HVO) opened at 171.4375 on Wednesday. The firm’s market capitalization is GBX 133.83 million. Hvivo PLC has a one year low of GBX 167.00 and a one year high of GBX 282.50. The firm has a 50-day moving average price of GBX 178.92 and a 200-day moving average price of GBX 186.41.
Separately, Numis Securities Ltd reissued an “add” rating and issued a GBX 210 ($2.60) price target on shares of Hvivo PLC in a report on Thursday, September 22nd.
About Hvivo PLC
hVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold.
Receive News & Ratings for Hvivo PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hvivo PLC and related companies with MarketBeat.com's FREE daily email newsletter.